150 related articles for article (PubMed ID: 33257979)
1. Targeted RNA-Sequencing Enables Detection of Relevant Translocations and Single Nucleotide Variants and Provides a Method for Classification of Hematological Malignancies-RANKING.
de Lange K; de Boer EN; Bosga A; Alimohamed MZ; Johansson LF; Mulder AB; Vellenga E; van Diemen CC; Deelen P; van den Berg E; Sikkema-Raddatz B
Clin Chem; 2020 Dec; 66(12):1521-1530. PubMed ID: 33257979
[TBL] [Abstract][Full Text] [Related]
2. Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies.
Kim B; Lee H; Shin S; Lee ST; Choi JR
J Mol Diagn; 2019 Jan; 21(1):163-170. PubMed ID: 30347268
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
[TBL] [Abstract][Full Text] [Related]
4. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
[TBL] [Abstract][Full Text] [Related]
5. Detection of 22 common leukemic fusion genes using a single-step multiplex qRT-PCR-based assay.
Lyu X; Wang X; Zhang L; Chen Z; Zhao Y; Hu J; Fan R; Song Y
Diagn Pathol; 2017 Jul; 12(1):55. PubMed ID: 28743306
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of more than 140 gene fusion variants and aberrant activation of EVI1 and TLX1 in hematological malignancies.
Ghasemian Sorbeni F; Montazersaheb S; Ansarin A; Esfahani A; Rezamand A; Sakhinia E
Ann Hematol; 2017 Oct; 96(10):1605-1623. PubMed ID: 28779353
[TBL] [Abstract][Full Text] [Related]
7. Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics.
Engvall M; Cahill N; Jonsson BI; Höglund M; Hallböök H; Cavelier L
BMC Med Genomics; 2020 Jul; 13(1):106. PubMed ID: 32727569
[TBL] [Abstract][Full Text] [Related]
8. RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia.
Shanmuganathan N; Wadham C; Thomson D; Shahrin NH; Vignaud C; Obourn V; Chaturvedi S; Yang F; Feng J; Saunders V; Kok CH; Yeung D; King RM; Kenyon RR; Lin M; Wang P; Scott H; Hughes T; Schreiber AW; Branford S
J Mol Diagn; 2022 Jul; 24(7):803-822. PubMed ID: 35550185
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
Wojcik I; Szybka M; Golanska E; Rieske P; Blonski JZ; Robak T; Bartkowiak J
Neoplasma; 2005; 52(4):318-24. PubMed ID: 16059649
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing.
Arindrarto W; Borràs DM; de Groen RAL; van den Berg RR; Locher IJ; van Diessen SAME; van der Holst R; van der Meijden ED; Honders MW; de Leeuw RH; Verlaat W; Jedema I; Kroes WGM; Knijnenburg J; van Wezel T; Vermaat JSP; Valk PJM; Janssen B; de Knijff P; van Bergen CAM; van den Akker EB; Hoen PAC'; Kiełbasa SM; Laros JFJ; Griffioen M; Veelken H
Leukemia; 2021 Jan; 35(1):47-61. PubMed ID: 32127641
[TBL] [Abstract][Full Text] [Related]
11. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
[TBL] [Abstract][Full Text] [Related]
12. Detection of Hybrid Fusion Transcripts, Aberrant Transcript Expression, and Specific Single Nucleotide Variants in Acute Leukemia and Myeloid Disorders with Recurrent Gene Rearrangements.
Li Y; Deng K; Kaner J; Geyer JT; Ouseph M; Fang F; Xu K; Roboz G; Kluk MJ
Pathobiology; 2024; 91(1):76-88. PubMed ID: 37490880
[TBL] [Abstract][Full Text] [Related]
13. Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia.
Shearer BM; Sukov WR; Flynn HC; Knudson RA; Ketterling RP
Am J Hematol; 2010 Aug; 85(8):569-74. PubMed ID: 20556821
[TBL] [Abstract][Full Text] [Related]
14. Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.
Liu D; Zhang Y; Chen S; Pan J; He X; Liang J; Chen Z
Cancer Genet; 2015 Jun; 208(6):333-40. PubMed ID: 26032184
[TBL] [Abstract][Full Text] [Related]
15. Detection of the t(11;14)(q13;q32) without CCND1/IGH fusion in a case of acute myeloid leukemia.
Tarsitano M; Palmieri S; Ferrara F; Riccardi C; Cavaliere ML; Vicari L
Cancer Genet Cytogenet; 2009 Dec; 195(2):164-7. PubMed ID: 19963117
[TBL] [Abstract][Full Text] [Related]
16. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
17. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
[TBL] [Abstract][Full Text] [Related]
18. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations.
Russell M; List A; Greenberg P; Woodward S; Glinsmann B; Parganas E; Ihle J; Taetle R
Blood; 1994 Aug; 84(4):1243-8. PubMed ID: 8049440
[TBL] [Abstract][Full Text] [Related]
19. PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies.
Duhoux FP; Ameye G; Montano-Almendras CP; Bahloula K; Mozziconacci MJ; Laibe S; Wlodarska I; Michaux L; Talmant P; Richebourg S; Lippert E; Speleman F; Herens C; Struski S; Raynaud S; Auger N; Nadal N; Rack K; Mugneret F; Tigaud I; Lafage M; Taviaux S; Roche-Lestienne C; Latinne D; Libouton JM; Demoulin JB; Poirel HA; ;
Br J Haematol; 2012 Jan; 156(1):76-88. PubMed ID: 22050763
[TBL] [Abstract][Full Text] [Related]
20. Delineation of known and new transcript variants of the SETMAR (Metnase) gene and the expression profile in hematologic neoplasms.
Jeyaratnam DC; Baduin BS; Hansen MC; Hansen M; Jørgensen JM; Aggerholm A; Ommen HB; Hokland P; Nyvold CG
Exp Hematol; 2014 Jun; 42(6):448-56.e4. PubMed ID: 24607956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
